INT230-6
OTT 20-11 (IT-02)
Phase 2 small_molecule active
Quick answer
INT230-6 for Breast Cancer is a Phase 2 program (small_molecule) at INTENSITY THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- INTENSITY THERAPEUTICS, INC.
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active